Skip to main content
A

AOTI, Inc. — Investor Relations & Filings

Ticker · AOTI ISIN · US03690C1027 LEI · 213800ZGCNDSTWIRK687 IL Manufacturing
Open in API
Filings indexed 44 across all filing types
Latest filing 2026-05-01 Regulatory Filings
Country US United States of America
Listing IL AOTI

About AOTI, Inc.

https://aotinc.net

AOTI, Inc. (Advanced Oxygen Therapy Inc.) is a medical technology company specializing in solutions for chronic non-healing and complex acute wounds. The company's primary product is the patented Topical Wound Oxygen (TWO2) therapy, a multi-modality system designed for patient use at home. This therapy combines high-pressure topical oxygen, non-contact cyclical compression, and controlled humidity to promote durable healing. It is primarily used for treating conditions such as Diabetic Foot Ulcers (DFUs) and venous leg ulcers. Clinical evidence demonstrates that TWO2 therapy effectively reduces amputations, hospitalizations, and wound recurrence, leading to improved patient outcomes and lower overall healthcare costs.

Recent filings

Filing Released Lang Actions
Employee Share Purchase Plan
Regulatory Filings
2026-05-01 English
Real-world study of AOTI’s TWO2® therapy
Regulatory Filings Classification · 1% confidence The document is an RNS press release announcing clinical study results for a medical therapy. It is not a formal financial report (Annual, Interim, or Earnings Release), nor does it announce governance, financing, or capital changes. It is a general regulatory announcement via RNS that falls into the ‘miscellaneous filings’ category.
2026-04-27 English
Grant of awards under Long Term Incentive Plan
Director's Dealing Classification · 1% confidence The document is an RNS announcement detailing the grant of performance share awards (options) to PDMRs (CEO, CFO, COO) under the LTIP, describing volumes, prices, dates and nature of the award. This falls under insider share transactions by directors and executives, matching the definition of “Director's Dealing.”
2026-04-23 English
2025 Annual Report and Notice of AGM
Report Publication Announcement Classification · 1% confidence The document is an RNS announcement dated 21 April 2026 stating that the Company’s Annual Report and Financial Statements for the year ended 31 December 2025, together with the Notice of Annual General Meeting, Form of Instruction, and Proxy forms will shortly be available on the Company’s website. It does not contain the full Annual Report or Notice itself but announces the publication and availability of those documents. This matches the definition of a Report Publication Announcement (Code: RPA).
2026-04-21 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an RNS announcement under Article 19 of the Market Abuse Regulation detailing personal share transactions by a director and person closely associated (Mr and Mrs Lefort). It reports the distribution of shares back to them, their aggregate holdings, and is a Mandatory Insider/Director dealing disclosure. This matches the definition for Director's Dealing (DIRS).
2026-04-02 English
Final Results
Earnings Release Classification · 1% confidence The document is an RNS announcement titled “2025 Final Results” providing audited results for the year ended 31 December 2025, with operational and financial highlights, CEO and Chair commentary, and outlook. It is clearly the initial public release of the company’s full‐year financial performance, not a full statutory annual report (10‐K) or interim report, and it presents key earnings metrics. This matches the definition of an Earnings Release (ER). FY 2025
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.